A scoping review and evidence mapping analysis evaluated how exercise interventions alleviate chemotherapy-induced peripheral neuropathy across different neurotoxic chemotherapy protocols. Researchers reviewed literature published between 2018 and 2025 to characterize intervention parameters and reported clinical outcomes in cancer patients undergoing treatment.
The synthesis identified 31 qualifying studies, of which 77.4 percent were randomized controlled trials. Across the evaluated study populations, 77.4 percent received taxane-based chemotherapy regimens, while 61.3 percent were treated with platinum-based agents. Notably, only 12.5 percent of the analyzed investigations focused specifically on post-treatment cancer survivors.
Multimodal exercise regimens emerged as the predominant intervention design, representing 58.1 percent of the examined programs. These structured physical activities were delivered across clinical settings using home-based, directly supervised, and hybrid formats, though participant adherence was tracked primarily through subjective self-report tools.
The primary outcome measures assessed across the evidence base centered on patient-reported neuropathic symptom severity and overall health-related quality of life. The reviewers noted substantial heterogeneity across individual study designs, including varied exercise modalities, intervention lengths, and clinical assessment instruments.
Methodological quality assessments conducted with the Mixed Methods Appraisal Tool demonstrated higher reporting quality for established interventions, such as aerobic and resistance training, which scored between 4 and 5. Less conventional approaches, including neurodynamic movements and therapeutic dance, exhibited lower reporting standards.
The review concludes that physical exercise represents a feasible supportive strategy for mitigating neuropathy burden. However, scarce agent-specific reporting and non-standardized exercise protocols continue to prevent definitive conclusions regarding optimal interventions for specific neurotoxic drugs.
To identify relevant publications, the investigators conducted comprehensive searches across PubMed, Web of Science, and Scopus databases in strict adherence to the PRISMA-ScR guidelines. Methodological quality across the reviewed corpus was appraised using the Mixed Methods Appraisal Tool, while evidence patterns were visually mapped using bubble plots categorizing specific neurotoxic agents alongside distinct exercise types.
The synthesized findings highlighted that exercise functions as a feasible and potentially effective supportive care approach to diminish the symptom burden of chemotherapy-induced peripheral neuropathy. Nevertheless, high-quality investigations providing transparent distribution data for neurotoxic agents and utilizing standardized intervention protocols remain sparse across the medical literature. This reporting deficit impedes researchers from drawing direct comparisons across individual chemotherapy agents, ultimately precluding definitive drug-specific recommendations.
Consequently, the authors emphasized that therapeutic physical interventions must be tailored according to specific neurotoxic chemotherapy regimens as well as patients’ heterogeneous clinical presentations. They recommended integrating these personalized regimens into multidisciplinary supportive cancer care pathways alongside objective monitoring approaches rather than relying entirely on unverified patient self-reporting tools.
Subject of Research: Exercise interventions for chemotherapy-induced peripheral neuropathy management
Article Title: Exercise interventions in the management of peripheral neuropathy according to neurotoxic chemotherapy agents: A scoping review and evidence mapping
Article References: Eroğlu, İ., & Kutlutürkan, S. (2026). Exercise interventions in the management of peripheral neuropathy according to neurotoxic chemotherapy agents: A scoping review and evidence mapping. Supportive Care in Cancer, 34(12), Article 1259. https://doi.org/10.1007/s00520-026-11496-y
Image Credits: AI Generated
DOI: 10.1007/s00520-026-11496-y
Keywords: chemotherapy-induced peripheral neuropathy, exercise interventions, scoping review, evidence mapping, taxane chemotherapy, platinum chemotherapy, multimodal exercise, supportive care in cancer, aerobic exercise, resistance training, randomized controlled trials, neuropathic symptoms, quality of life, mixed methods appraisal tool, neurotoxic agents, cancer rehabilitation
News Source: Nathaniel Bowman. (November 20, 2026). Exercise Mapping Clarifies Supportive Care for Chemotherapy-Induced Peripheral Neuropathy. Scienmag.



